Explore the critical link between impaired brain oxygenation response and the heightened danger of recurrent strokes in patients with symptomatic large vessel disease—a pivotal insight for neurosurgical interventions.
– by Marv
Note that Marv is a sarcastic GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Increased Risk of Recurrent Stroke in Symptomatic Large Vessel Disease With Impaired BOLD Cerebrovascular Reactivity.
van Niftrik et al., Stroke 2024
<!– DOI: 10.1161/STROKEAHA.123.044259 //–>
https://doi.org/10.1161/STROKEAHA.123.044259
Oh, what a joyous day for the world of cerebrovascular reactivity (CVR)! After years of head-scratching and complex, time-devouring techniques that left clinicians more puzzled than a chameleon in a bag of Skittles, the brilliant minds of science have bestowed upon us a revolutionary method. They’ve taken the good ol’ blood-oxygenation-level-dependent (BOLD) MRI signal, thrown in a dash of hypercapnic stimulus (because who doesn’t love a bit of extra CO2), and voilà! We now have a universally comparable CVR assessment that’s as standardized as a No. 2 pencil.
But wait, there’s more! These intrepid researchers didn’t just stop at inventing this shiny new tool; they put it to the test in a retrospective extravaganza featuring patients with the ever-so-troublesome symptomatic cerebrovascular large vessel disease. These lucky individuals had the honor of undergoing the BOLD-CVR protocol at a single, very special tertiary stroke referral center between the summer of ’14 and the spring of ’20. And because everyone loves a good follow-up, these patients were stalked—I mean, monitored—for up to three thrilling years to see who would win the unfortunate lottery of recurrent acute ischemic events.
Now, brace yourselves for the statistical sorcery: BOLD-CVR was calculated on a voxel-by-voxel basis (because who needs simplicity?), and an impaired BOLD-CVR was defined as being 2 SD below the mean of a healthy right hemisphere from a whopping reference cohort of 20 people. Yes, you read that right—20 whole individuals! Using the magical multivariate Cox proportional hazards model and the ever-so-illustrative Kaplan-Meier survival curves, the researchers found that impaired BOLD-CVR, along with a history of atrial fibrillation and heart insufficiency, were the life of the recurrent stroke party.
And the grand finale? After adjusting for trivialities like sex, age group, and atrial fibrillation, it turns out that having an impaired BOLD-CVR gives you a 10.73 times higher chance of a repeat stroke performance. So, for those with symptomatic cerebrovascular large vessel disease, if your BOLD-CVR is not up to snuff in the affected hemisphere, you might want to keep your neurologist on speed dial.
But let’s not forget, this is all retrospective, single-center gospel. So, take it with a grain of salt—or maybe a whole salt shaker.